









市场行情
/
股票
/
nasdaq-rxst
/

Rxsight Inc

RXST

10.930USD

-0.530-4.62%

收盘 12/26, 16:00（美东）报价延迟15分钟

449.02M总市值

亏损市盈率 TTM



Rxsight Inc

10.930

-0.530-4.62%

概览公司财务分析

概览

公司

财务

分析

关于 Rxsight Inc 公司

RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Rxsight Inc简介



公司代码RXST

公司名称Rxsight Inc

上市日期Jul 30, 2021

CEOKurtz (Ron M)

员工数量498

证券类型Ordinary Share

年结日Jul 30

公司地址100 Columbia Street

城市ALISO VIEJO

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编92656

电话19495217822

网址https://www.rxsight.com/

公司代码RXST

上市日期Jul 30, 2021

CEOKurtz (Ron M)

Rxsight Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Eric Weinberg

Co-President, Chief Commercial Officer

496.25K

+60.99%

Dr. Ilya Goldshleger, Ph.D.

Co-President, Chief Operating Officer

67.06K

+53.75%

Dr. William J. Link, Ph.D.

Independent Director

59.10K

+22.24%

Mr. Robert J. (Bob) Palmisano

Independent Director

41.04K

+35.50%

Ms. Shelley B. Thunen

Co-President, Chief Financial Officer

38.35K

-1.26%

Ms. Shweta Singh Maniar

Independent Director

18.14K

+145.63%

Dr. Ron M. Kurtz, M.D.

President, Chief Executive Officer, Director

Ms. Juliet Tammenoms Bakker

Independent Director

Mr. J. Andy Corley

Independent Chairman of the Board

Ms. Julie B. Andrews

Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Eric Weinberg

Co-President, Chief Commercial Officer

496.25K

+60.99%

Dr. Ilya Goldshleger, Ph.D.

Co-President, Chief Operating Officer

67.06K

+53.75%

Dr. William J. Link, Ph.D.

Independent Director

59.10K

+22.24%

Mr. Robert J. (Bob) Palmisano

Independent Director

41.04K

+35.50%

Ms. Shelley B. Thunen

Co-President, Chief Financial Officer

38.35K

-1.26%

Ms. Shweta Singh Maniar

Independent Director

18.14K

+145.63%

收入明细

FY2024

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

139.93M

0.00%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

5.47%

Millennium Management LLC

5.33%

The Vanguard Group, Inc.

5.22%

D. E. Shaw & Co., L.P.

4.46%

Artisan Partners Limited Partnership

4.27%

其他

75.25%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

5.47%

Millennium Management LLC

5.33%

The Vanguard Group, Inc.

5.22%

D. E. Shaw & Co., L.P.

4.46%

Artisan Partners Limited Partnership

4.27%

其他

75.25%

股东类型

持股股东

占比

Investment Advisor

34.73%

Hedge Fund

24.74%

Investment Advisor/Hedge Fund

13.27%

Research Firm

7.17%

Individual Investor

5.59%

Pension Fund

1.07%

Private Equity

0.56%

Bank and Trust

0.28%

Family Office

0.06%

其他

12.53%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

449

38.67M

94.05%

-9.26M

2025Q2

446

40.83M

100.45%

-3.67M

2025Q1

453

40.49M

99.79%

-7.96M

2024Q4

440

38.96M

96.23%

-5.07M

2024Q3

420

38.15M

94.75%

-3.92M

2024Q2

391

37.00M

93.42%

-2.64M

2024Q1

338

34.63M

93.15%

-2.60M

2023Q4

299

33.17M

91.51%

-284.01K

2023Q3

253

34.41M

96.36%

-1.84M

2023Q2

214

31.39M

90.12%

+2.22M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

2.51M

6.13%

-48.31K

-1.89%

Jun 30, 2025

Millennium Management LLC

2.61M

6.38%

+1.66M

+174.50%

Jul 09, 2025

The Vanguard Group, Inc.

2.27M

5.55%

-113.59K

-4.76%

Jun 30, 2025

D. E. Shaw & Co., L.P.

1.32M

3.23%

+1.30M

+5906.05%

Jun 30, 2025

Artisan Partners Limited Partnership

2.25M

5.51%

+485.02K

+27.44%

Jun 30, 2025

NO STREET GP LP

1.20M

2.93%

+600.00K

+100.00%

Jun 30, 2025

Two Sigma Investments, LP

621.86K

1.52%

+408.47K

+191.42%

Jun 30, 2025

Citadel Advisors LLC

1.03M

2.51%

+797.64K

+346.47%

Jun 30, 2025

DWS Investments UK Limited

1.22M

2.99%

+566.62K

+86.54%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

State Street SPDR S&P Health Care Equipment ETF

0.62%

ProShares Hedge Replication ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

iShares Morningstar Small-Cap Value ETF

0.01%

iShares Russell 2000 ETF

0.01%

WisdomTree US SmallCap Fund

0.01%

Schwab U.S. Small-Cap ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Global X Russell 2000 ETF

0.01%

Proshares Ultra Russell 2000

0.01%

State Street SPDR S&P Health Care Equipment ETF

占比0.62%

ProShares Hedge Replication ETF

占比0.02%

iShares Russell 2000 Growth ETF

占比0.02%

iShares Morningstar Small-Cap Value ETF

占比0.01%

iShares Russell 2000 ETF

占比0.01%

WisdomTree US SmallCap Fund

占比0.01%

Schwab U.S. Small-Cap ETF

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

Global X Russell 2000 ETF

占比0.01%

Proshares Ultra Russell 2000

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Rxsight Inc的前五大股东是谁？



Rxsight Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：2.51M，占总股份比例：6.13%。
Millennium Management LLC持有股份：2.61M，占总股份比例：6.38%。
The Vanguard Group, Inc.持有股份：2.27M，占总股份比例：5.55%。
D. E. Shaw & Co., L.P.持有股份：1.32M，占总股份比例：3.23%。
Artisan Partners Limited Partnership持有股份：2.25M，占总股份比例：5.51%。